Protocol Name: Study of Efficacy and Safety of Iptacopan in Participants With Active Lupus Nephritis Class III-IV, +/- V
Protocol #: CLNP023K12201
Indication: Lupus Nephritis
GFR: ≥ 25
Protocol Name: Study of Efficacy and Safety of Iptacopan in Participants With Active Lupus Nephritis Class III-IV, +/- V
Protocol #: CLNP023K12201
Indication: Lupus Nephritis
GFR: ≥ 25